Joel Greenblatt Bio Rad Laboratories, Inc. Transaction History

Gotham Asset Management, LLC

$16.1 Billion
Q2 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 87,863 shares of BIO stock, worth $29.1 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

87,863

Previous 28,466 208.66%

Holding current value

$29.1 Million

Previous $6.93 Million 205.83%

% of portfolio

0.13%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$216.56 - $256.68 $12.9 Million - $15.2 Million	59,397 Added 208.66%	87,863 $21.2 Million
Q1 2025 May 15, 2025	BUY	$243.0 - $367.0 $1.58 Million - $2.39 Million	6,517 Added 29.69%	28,466 $6.93 Million
Q4 2024 Feb 14, 2025	BUY	$313.15 - $374.28 $1.19 Million - $1.42 Million	3,805 Added 20.97%	21,949 $7.21 Million
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $2.79 Million - $3.64 Million	-10,552 Reduced 36.77%	18,144 $6.07 Million
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $1.26 Million - $1.59 Million	-4,690 Reduced 14.05%	28,696 $7.84 Million
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $1.22 Million - $1.42 Million	-4,028 Reduced 10.77%	33,386 $11.5 Million
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $3.97 Million - $5.38 Million	14,743 Added 65.03%	37,414 $12.1 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $6.27 Million - $7.56 Million	17,891 Added 374.29%	22,671 $8.13 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $703,521 - $951,884	1,957 Added 69.32%	4,780 $1.81 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $321,553 - $386,304	768 Added 37.37%	2,823 $1.35 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $50,646 - $65,665	144 Added 7.54%	2,055 $864,000
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $604,444 - $825,175	-1,465 Reduced 43.39%	1,911 $797,000
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $1.5 Million - $1.93 Million	-3,236 Reduced 48.94%	3,376 $1.67 Million
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $542,929 - $761,159	-1,035 Reduced 13.53%	6,612 $3.72 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $4.34 Million - $4.87 Million	6,125 Added 402.43%	7,647 $5.78 Million
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $834,633 - $1.05 Million	-1,269 Reduced 45.47%	1,522 $1.14 Million
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $1.86 Million - $2.1 Million	-3,233 Reduced 53.67%	2,791 $1.8 Million
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $2.39 Million - $2.9 Million	4,376 Added 265.53%	6,024 $3.44 Million
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $316,621 - $398,939	-620 Reduced 27.34%	1,648 $961,000
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $5.73 Million - $6.76 Million	-12,613 Reduced 84.76%	2,268 $1.17 Million
Q2 2020 Aug 13, 2020	SELL	$334.87 - $493.06 $1.07 Million - $1.57 Million	-3,189 Reduced 17.65%	14,881 $6.72 Million
Q1 2020 May 15, 2020	SELL	$320.01 - $409.07 $623,059 - $796,459	-1,947 Reduced 9.73%	18,070 $6.34 Million
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $478,955 - $560,551	1,498 Added 8.09%	20,017 $7.41 Million
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $3.48 Million - $3.94 Million	11,411 Added 160.54%	18,519 $6.16 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $1.36 Million - $1.48 Million	4,731 Added 199.03%	7,108 $2.22 Million
Q1 2019 May 15, 2019	SELL	$224.3 - $317.41 $1.13 Million - $1.6 Million	-5,026 Reduced 67.89%	2,377 $727,000
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $88,260 - $123,909	401 Added 5.73%	7,403 $1.72 Million
Q3 2018 Nov 14, 2018	BUY	$289.28 - $326.15 $2.03 Million - $2.28 Million	7,002 New	7,002 $2.19 Million

Others Institutions Holding BIO

# of Institutions

430

Shares Held

19.2M

Call Options Held

10.7K

Put Options Held

35.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.16B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account